Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China · Delayed Price · Currency is CNY 13.45
+0.08 (0.60%)
Apr 28, 2026, 3:04 PM CST
SHE:002675 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 204.33 | 195.63 | 183.83 | 209.74 | 307.29 | 151.56 |
Depreciation & Amortization | 196.53 | 196.53 | 164.95 | 147.25 | 125.09 | 114.93 |
Other Amortization | 23.83 | 23.83 | 9.53 | 6.2 | 5.35 | 4.53 |
Loss (Gain) From Sale of Assets | -0.08 | -0.08 | -0.3 | -0.06 | -0.13 | 0.15 |
Asset Writedown & Restructuring Costs | 0.41 | 0.41 | 85.9 | -1.33 | 80.62 | 211.42 |
Loss (Gain) From Sale of Investments | 15.88 | 15.88 | 12.92 | 8.54 | 39.21 | 12.15 |
Provision & Write-off of Bad Debts | 14.2 | 14.2 | 16.44 | -5.19 | 2.56 | 1.47 |
Other Operating Activities | -53.92 | 100.22 | 37.02 | 216.15 | 69.69 | 152.95 |
Change in Accounts Receivable | -53.99 | -53.99 | -124.86 | 174.75 | -23.63 | 129.89 |
Change in Inventory | 112.13 | 112.13 | 261.39 | 66.11 | -112.36 | 10.51 |
Change in Accounts Payable | 14.18 | 14.18 | -447.96 | -524.11 | 330.58 | 176.68 |
Change in Other Net Operating Assets | -4.23 | -4.23 | 95.84 | 3.67 | 175.61 | -16.74 |
Operating Cash Flow | 434.42 | 579.85 | 287.15 | 276.94 | 996.54 | 943.58 |
Operating Cash Flow Growth | -23.32% | 101.93% | 3.69% | -72.21% | 5.61% | 64.80% |
Capital Expenditures | -361.28 | -360.82 | -456.09 | -511.95 | -389.61 | -530.16 |
Sale of Property, Plant & Equipment | 0.51 | 0.54 | 0.72 | 1.08 | 0.45 | 0.29 |
Cash Acquisitions | - | - | -3.46 | -202.19 | 0.03 | - |
Divestitures | -0 | -0 | - | - | - | - |
Investment in Securities | -143.36 | -200.18 | -264.04 | 78.15 | -72.51 | -214.78 |
Other Investing Activities | 6.68 | 5.79 | 7.88 | 32.1 | 8.89 | 5.41 |
Investing Cash Flow | -497.45 | -554.67 | -715 | -602.8 | -452.75 | -739.25 |
Long-Term Debt Issued | - | 501.24 | 887.09 | 558.36 | 526.68 | 588.55 |
Total Debt Issued | 573.2 | 501.24 | 887.09 | 558.36 | 526.68 | 588.55 |
Short-Term Debt Repaid | - | - | - | -7 | -8.06 | - |
Long-Term Debt Repaid | - | -731.54 | -815.86 | -460.2 | -912.74 | -540.03 |
Total Debt Repaid | -514.02 | -731.54 | -815.86 | -467.2 | -920.8 | -540.03 |
Net Debt Issued (Repaid) | 59.18 | -230.29 | 71.23 | 91.16 | -394.12 | 48.52 |
Issuance of Common Stock | 301.82 | 416.98 | 689.6 | 166.5 | 286.24 | 65.28 |
Common Dividends Paid | -105.62 | -110.37 | -217.25 | -258.33 | -251.24 | -302.48 |
Other Financing Activities | -63.75 | 10 | - | - | - | - |
Financing Cash Flow | 191.63 | 86.32 | 543.58 | -0.68 | -359.13 | -188.68 |
Foreign Exchange Rate Adjustments | -8.48 | -2.39 | 12.15 | 7.42 | 6.26 | 6.75 |
Net Cash Flow | 120.12 | 109.1 | 127.88 | -319.11 | 190.93 | 22.4 |
Free Cash Flow | 73.13 | 219.03 | -168.94 | -235 | 606.93 | 413.42 |
Free Cash Flow Growth | -50.87% | - | - | - | 46.80% | 33.20% |
Free Cash Flow Margin | 2.73% | 7.99% | -5.89% | -7.17% | 16.94% | 10.57% |
Free Cash Flow Per Share | 0.09 | 0.27 | -0.20 | -0.28 | 0.75 | 0.52 |
Cash Income Tax Paid | 219.9 | 201.06 | 146.99 | 145.68 | -4.72 | 41.63 |
Levered Free Cash Flow | 36.01 | 180.87 | -237.66 | -358.67 | 282.45 | 181.52 |
Unlevered Free Cash Flow | 127.44 | 266.83 | -177.34 | -323.2 | 319.1 | 216.8 |
Change in Working Capital | 33.24 | 33.24 | -223.12 | -304.33 | 366.86 | 294.42 |
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.